Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10031760 | 0.96 | MEN1 (0.31) | ALDH1A1ALOX12 | |
| SCHEMBL13041856 | 0.89 | ADRA2A (0.33) | ALOX12 | |
| SCHEMBL126873 | 0.89 | ADRA2A (0.33) | ALOX12 | |
| SCHEMBL16884595 | 0.87 | ALDH1A1 (0.33) | ALDH1A1ALOX12 | |
| SCHEMBL20364862 | 0.87 | ALDH1A1 (0.33) | ALDH1A1ALOX12 | |
| SCHEMBL15147492 | 0.87 | ALDH1A1 (0.33) | ALDH1A1ALOX12 | |
| SCHEMBL17069547 | 0.87 | — | — | |
| SCHEMBL23915498 | 0.86 | SMN1; SMN2 (0.31) | ALDH1A1ALOX12 | |
| SCHEMBL15147540 | 0.85 | ALDH1A1 (0.31) | ALDH1A1ALOX12 | |
| SCHEMBL141048 | 0.84 | ADRA2A (0.36) | ALDH1A1ALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150005230-A1 | CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY | CERULEAN PHARMA INC. (US) | 2015-01-01 | — | — | US | disclosed |
| US-20130131013-A1 | CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTICS DELIVERY | CERULEAN PHARMA INC. (US) | 2013-05-23 | — | — | US | disclosed |
| US-8110179-B2 | Cyclodextrin-based polymers for therapeutics delivery | CERULEAN PHARMA INC. (US) | 2012-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150005230-A1 | CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY | CDR2, DDOST, GALC | ALDH1A1 2989/4885ALOX12 3900/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.